Glazer Capital, LLC Verona Pharma PLC Transaction History
Glazer Capital, LLC
- $2.98 Billion
- Q3 2025
A detailed history of Glazer Capital, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Glazer Capital, LLC holds 3,205,878 shares of VRNA stock, worth $343 Million. This represents 11.48% of its overall portfolio holdings.
Number of Shares
3,205,878Holding current value
$343 Million% of portfolio
11.48%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
293Shares Held
84.9MCall Options Held
984KPut Options Held
3.11M-
Janus Henderson Group PLC London, X06.13MShares$656 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$589 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million16.88% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...